When: Clean reclaim above $202 with price at $200

Then: Add another 10% of position

When: Breakout above $225 with >4M volume and MACD positive

Then: Add final 5% of position

BUY

• Trim 25% of position (not 40%) in two tranches: 12.5% at $215 trigger, another 12.5% at $218 if tagged, to avoid single-block execution into resistance with MACD bearish divergence
• Stop revised to $207 (lower Bollinger band region, ~2 ATR below current price) instead of $202 to avoid being stopped out on noise during death cross unwind
• Re-entry framework is binary: re-add at $200 if it tags, or re-add on confirmation of Fed dovish pivot, whichever comes first
• If neither re-entry trigger materializes within two quarters, accept the trim monetizing a 22% rally and treat residual core position as long-term compounder with trailing stop at $207
• Q2'26 EPS at $1.23 versus Q2'25 at $0.77 = 60% YoY increase; aggressive analyst's 460bps sequential margin compression is from elevated Q1'26 seasonality, not structural collapse
• Q2'26 operating margin of 18.0% is within normal range (prior two-year base rates: 12.8% and 19.1%), not a structural reset
• Polymarket pricing 34% hike odds (up 7pp week-over-week) but 64% probability of no change = 'extended pause with hawkish tail risk,' not a hiking regime
• Duration-sensitive multiples have already compressed significantly; multiple compression trade is largely done, making aggressive analyst's macro positioning premature
• Asymmetric risk is dovish surprise relief rally, not hawkish surprise—aggressive analyst is positioned for the wrong tail
• Neutral analyst's $190-195 buy zone is an anchoring trap; stock may chop in $200-225 range for two quarters without visiting that level
• Holding full position through death cross with debt-financed acquisition overhang is stubborn, not conservative; but 40% trim is overreaction—25% acknowledges risk without abandoning a $5B free cash flow franchise

→ vs aggressive: Selling 25-40% at $215 into upper Bollinger band with MACD bearish divergence is 'selling into the noise,' not capital preservation; if wrong by five trading days on $200 SMA retest with $5-7 overshoot, 30-40% sold at wrong end of range with no ammunition to buy back

→ vs aggressive: Q2'26 EPS 'deterioration' framing is intellectually dishonest; 60% YoY increase ($1.23 vs $0.77) contradicts structural margin compression narrative; 460bps sequential compression is from elevated Q1'26 timing/revenue recognition seasonality, not structural reset

→ vs aggressive: Macro framing 'collapses under its own weight'; Polymarket pricing 34% hike vs 64% no change = 'extended pause with hawkish tail risk,' not hiking regime; duration multiples already compressed; asymmetric risk is dovish surprise relief rally, not hawkish surprise

→ vs neutral: $190-195 buy zone is same anchoring trap in reverse; stock may chop in $200-225 range for two quarters without visiting buy zone, leaving firm underweight in name generating $5B annual free cash flow

HOLD with trim

• Trim 25-30% of DHR position executed in three tranches: 10% at 215, 10% at 218, 10% at any push above 220
• Set stop at 203 (confluence of 200 SMA, Bollinger middle band, and prior breakout support), representing 1.8 ATRs below current price
• Re-entry triggers: 10% at 207 with confirmed MACD bullish crossover, 10% at 200 with close below 200 and reclaim above 202 within 5 trading days, 10% on breakout above 225 with volume confirmation
• Q2'26 EPS of 1.23 represents 60% YoY increase from Q2'25 EPS of 0.77; Q1'26 EPS of 1.45 was an outlier driven by timing effects
• Operating margin normalization from 22.6% in Q1'26 to 18.0% in Q2'26 is mean reversion, not structural collapse
• DHR added $6.5B new debt to fund ~$10B acquisition, pushing net debt up 61% in 90 days—balance sheet transformation takes 4-6 quarters to digest
• Death cross structure (50 SMA at 196.05 vs 200 SMA at 202.36) is unwinding in real time with 50 SMA rising from ~178; price trading 9.7% above 50 SMA
• Polymarket pricing 64% probability of no Fed change and 34% hike probability suggests base case is hold with hawkish tail risk, not active hiking regime
• DHR beta of 0.80 provides defensive ballast in muddle-through scenario but doesn't protect against broad multiple compression in hawkish surprise
• Macro view should be underwritten but not traded—DHR price already reflects meaningful probability of extended pause
• Do not rotate into momentum names on trim; redeploy only into positions that genuinely improve portfolio risk-adjusted return

→ vs aggressive: Frames Q2'26 sequential EPS decline as 'structural margin compression' but ignores that Q1'26 at 1.45 was an outlier high from timing effects and revenue mix; Q2'26 EPS of 1.23 versus Q2'25 EPS of 0.77 is a 60% YoY increase, not structural collapse

→ vs aggressive: Claims multiple compression hasn't shown up in stock while simultaneously arguing hawkish Fed pricing requires compression—cannot argue both that compression is required and that it hasn't happened

→ vs aggressive: Death cross argument overstated: 50 SMA at 196.05 is rising from ~178 bottom and unwinding itself; price has reclaimed both moving averages and sits 9.7% above 50 SMA; single MACD divergence at upper Bollinger in confirmed uptrend is often pause signal, not reversal

→ vs aggressive: 40% trim sizing is overreaction; 25-30% trim acknowledges asymmetric risk without capitulating

→ vs conservative: Binary re-entry framework ('add at 200 if it tags or on Fed dovish pivot') is too rigid; tying re-entry to subjective Fed call creates whipsaw risk and may cause missed moves

→ vs conservative: $207 stop is too tight at ~1.2 ATR; DHR has 6.82 ATR and such tight stops get hit on routine intraday swings, crystallizing losses before recovery

→ vs conservative: Overweighting franchise quality and DBS as static defensive characteristics; 61% net debt increase in 90 days from acquisition creates materially different risk profile than prior cycles

→ vs conservative: 25% trim is too modest given balance sheet transformation, valuation not cheap, and hawkish macro headwinds